Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06575725 |
Title | Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Metastatic Microsatellite Stable Colorectal Cancer |
Recruitment | Withdrawn |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | City of Hope Medical Center |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries |